Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-019211
Filing Date
2022-03-16
Accepted
2022-03-16 16:08:12
Documents
2
Period of Report
2022-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2144
2 POA DOCUMENT poa.txt EX-24 4050
  Complete submission text file 0001209191-22-019211.txt   7799
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O SEATTLE GENETICS, INC. 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
HIMES VAUGHN B (Reporting) CIK: 0001361966 (see all company filings)

Type: 3 | Act: 34 | File No.: 033-80623 | Film No.: 22744946